Mechanism of multidrug resistance in relation to passive membrane permeation

被引:49
作者
Eytan, GD [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel
关键词
multidrug resistance; transbilayer movement; drug flip-flop;
D O I
10.1016/j.biopha.2005.01.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Passive uptake of drugs into cells is described in terms of the following steps: (1) massive immediate binding of the drugs to the outer leaflet of the plasma membrane resulting in practical equilibrium between extremely high drug concentrations at the cell surface compared to the drug concentration in the medium. (2) Due to their amphipathic nature, anticancer drugs are practically excluded from the lipid core of the membrane. They cross the lipid core by distinct flip-flop events that occur in the case of doxorubicin and daunorubicin after an average period of 0.7 and 0.15 min, respectively. (3) The drug reaching the inner leaflet of the plasma membrane is in practical equilibrium with the drug present in the cytoplasm. (4) Almost all the amounts of anticancer drugs present in the cells are bound by molecular sinks, such as DNA or cytoskeleton elements. The resistance afforded to multidrug resistant (MDR) cells by extrusion pumps, such as P-glycoprotein, is negatively correlated with the affinity of the drugs to the membranes and with their flip-flop rates across membranes. Binding rates of the drugs to membranes and intracellular sinks have no effect on drug concentration in the cytoplasm once equilibrium is reached between the passive uptake of drugs and their active extrusion. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 22 条
[1]  
ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
[2]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[4]   Functional cell surface expression of band 3, the human red blood cell anion exchange protein (AE1), in K562 erythroleukemia cells: Band 3 enhances the cell surface reactivity of Rh antigens [J].
Beckmann, R ;
Smythe, JS ;
Anstee, DJ ;
Tanner, MJA .
BLOOD, 1998, 92 (11) :4428-4438
[5]   Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP [J].
Bolhuis, H ;
vanVeen, HW ;
Brands, JR ;
Putman, M ;
Poolman, B ;
Driessen, AJM ;
Konings, WN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) :24123-24128
[6]   Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity [J].
Borgnia, MJ ;
Eytan, GD ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3163-3171
[7]   Mechanism of action of p-glycoprotein in relation to passive membrane permeation [J].
Eytan, GD ;
Kuchel, PW .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 190, 1999, 190 :175-250
[8]   Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Hurwitz, CD ;
Assaraf, YG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (01) :104-112
[9]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[10]   COMPARISON OF THE MEMBRANE-TRANSPORT OF ANTHRACYCLINE DERIVATIVES IN DRUG-RESISTANT AND DRUG-SENSITIVE K562 CELLS [J].
FREZARD, F ;
GARNIERSUILLEROT, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 196 (02) :483-491